Cargando…
Recruitment of miR-8080 by luteolin inhibits androgen receptor splice variant 7 expression in castration-resistant prostate cancer
A need exists for seeking effective treatments for castration-resistant prostate cancer (CRPC) in response to its emergence following androgen deprivation therapy as a major clinical problem. In the present study, we investigated the chemopreventive and chemotherapeutic potential of luteolin, a flav...
Autores principales: | Naiki-Ito, Aya, Naiki, Taku, Kato, Hiroyuki, Iida, Keitaro, Etani, Toshiki, Nagayasu, Yuko, Suzuki, Shugo, Yamashita, Yoriko, Inaguma, Shingo, Onishi, Masaya, Tanaka, Yasuhito, Yasui, Takahiro, Takahashi, Satoru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422625/ https://www.ncbi.nlm.nih.gov/pubmed/31805186 http://dx.doi.org/10.1093/carcin/bgz193 |
Ejemplares similares
-
Luteolin suppresses bladder cancer growth via regulation of mechanistic target of rapamycin pathway
por: Iida, Keitaro, et al.
Publicado: (2020) -
NCL1, A Highly Selective Lysine-Specific Demethylase 1 Inhibitor, Suppresses Castration-Resistant Prostate Cancer Growth via Regulation of Apoptosis and Autophagy
por: Etani, Toshiki, et al.
Publicado: (2019) -
GPX2 promotes development of bladder cancer with squamous cell differentiation through the control of apoptosis
por: Naiki, Taku, et al.
Publicado: (2018) -
DPYD, down-regulated by the potentially chemopreventive agent luteolin, interacts with STAT3 in pancreatic cancer
por: Kato, Hiroyuki, et al.
Publicado: (2021) -
Early abiraterone acetate treatment is beneficial in Japanese castration-resistant prostate cancer after failure of primary combined androgen blockade
por: Nagai, Takashi, et al.
Publicado: (2018)